All rights reserved.
Sunnylife Pharma,Inc.
PIPELINE
Target strategy

•Targets with strong validation and ability to succeed clinically and in the market

•Strong understanding and expertise of chemistry and biology of chosen targets

Portfolio of small molecule drug discovery programs, such as
Obesity: Lead optimization
Cancer: Lead optimization
HCV: Lead optimization
Early stage programs in cancer
, glaucoma, cardiovascular disease and auto-immune disease.
  2013
2014
2015
2016
Obesity
Initiated
Lead optimization
Licensing
 
Cancer
 
Initiated
Lead optimization
PCC*
HCV
 
Initiated/Lead
optimization
PCC*
 
Cardiovascular
   
Initiate/Exploratory

Lead
optimization
PCC: A pre-clinical Candidate.